Member Info for JoeyDiamond

Indeed such is the mans ego I think he will mention our treatment tonight in his daily briefing. He was right after all about injecting directly into the lungs

I know this is such a dreadful share ;)

Some wonderful stories on this board of so many amateur investors making so much money whilst Acacia missed out. Warms the heart :)

He has form for claiming cures as we know and has been ridiculed for it.

Now he can claim he was right all along we have a miracle drug that he has procured for America. Hero of the hour trust the Donald the great businessman.

Tomorrow morning there is a chance (small one) but chance none the less that we £10+ share.

I think the Donald is tweeting about us there. He is starting up his daily briefings again today on Covid-19 at 5PM EST

Hes under big pressure with reopening the economy to early and many new infections/deaths, what better thing to deflect pressure by claiming a victory by a new theraputic in the pipeline that heals 80% people. If it doesnt work he can just blame the British :)

There is a chance at around 9pm tonight our time Synairgen gos nuclear as there is a big chance it becomes politicised

Mulitple big pharma all talking to Synairgen, bidding war hopefully :)

Gilead will be sweating as SNG001 once approved will replace their drug Remdesivir.

MMs hate the long term holders especially the ones like us that won't budge on our shares and will just use and retraces for topups. :)

They will also hate that our sentiment is ultra bullish and the paid derampers on here are having no effect.

I dont know of any long term holders (we all know who the LTH's on this board are) who are selling. We have waited patiently for months for the results all the time watching as price went to 34p as Acacia were selling. We know how game changing this treatment is.

Results were better than expected.
Coverage in media better than expected.
We will be fast tracked for approval.
Mentioned by Health Secretary in Parliament.
Appeared on USA news channels.
Own patent in both EU and USA.
We already have a stockpile of the treatment as company started producing in April such is the confidence.
We have COPD and other trials to be announced next month.
Big Pharma will be looking at this and a takeover/partnership is liely the next step.
Investment funds predicted £2-3 billion revenue by year end.

Market Cap only around 300 million atm. Hmm do the math :)

When so many paid deramper appear on a share they dont own you know you got gold. The MM's will try every trick in the book today to take your shares

Government have already announced they backing the large trial, this will be fast tracked.

I think Donald Trump will mention the treatment at his daily covid press conference today in order to justify his reopening of the economy too soon :)

Acacia were down to 2% on 17/07 I suspect they are now fully out with the huge volume yesterday.

This is defo as long term hold for £7 and beyond

Indeed many people have top sliced and day traders closed positions. I believe most are LTH's who are holding anywhere from £4 to 20 quid.

Around 1 billion market Cap = near £7 a share which I dont think is unreasonable when you look at treatments like Gileads.

Getting some more traction in USA now on CNN news site

- https://edition.cnn.com/2020/07/20/investing/synairgen-coronavirus-treatment/index.html

I would not be suprised if this new trial is held in the USA.

The public have very short memories and people love cheap fashion. Buy for me.

Im in at 2.15 and think we going straight back to 4 in a V shape recovery or is that a V neck recovery?

I can't believe so many people are mad that Orphidian and others made big bucks selling their holdings while telling you lot the opposite :)

Its the oldest trading trick in the book lol.

https://clinicaltrials.gov/ct2/show/record/NCT04385095?term=interferon&cond=covid-19&draw=2&view=record

Trial was registered with US library of medicine, interesting read

A government backed large scale trial utilising the NHS is a brilliant outcome, this accelerates the development of the treatment and bringing it to market sooner.